Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity

Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity

Abstract Background To evaluate the outcome of intravitreal bevacizumab (IVB) and aflibercept (IVA) injection for patients with retinopathy of prematurity (ROP). Methods In this single-center retrospective cohort, the recorded medical data of the infants who had been undergone intravitreal injection...

Full description

Bibliographic Details
Main Authors: Hamid Riazi-esfahani, Alireza Mahmoudi, Mehdi Sanatkar, Afsar Dastjani Farahani, Fatemeh Bazvand
Format: Article
Language:English
Published: BMC 2021-10-01
Series:International Journal of Retina and Vitreous
Subjects:
Retinopathy of prematurity
Bevacizumab
Aflibercept
Online Access:https://doi.org/10.1186/s40942-021-00334-4

Similar Items

Similar Items